Phase II Study of Range and Schedule of rPA Doses

Clinical trial NCT00170456 · COMPLETED

Trial details

NCT number: NCT00170456
Sponsor: PharmAthene UK Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prevention of Bacillus Anthracis (Anthrax) Infection

Start date: 2005-03-01
Primary completion: 2007-01-01
Enrollment: 415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.